Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full – 2011) http://www.nature.com/npp/journal/v3...pp201134a.html
Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study (full – 2011) http://www.ajop.co.za/Journals/Novem...abis%20use.pdf
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full – 2011) http://www.hindawi.com/journals/sprt/2011/501726/
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NB...d-Micelles.pdf
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full – 2011) http://jop.sagepub.com/content/26/1/144.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis, COMT and psychotic experiences (full – 2011) http://bjp.rcpsych.org/content/199/5/380.long
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...h-05-00063.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives (full – 2011) http://jop.sagepub.com/content/26/1/150.full.pdf+html
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full – 2011) http://www.schres-journal.com/articl...224-6/fulltext
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21458498
Synthetic cannabinoid JWH-018 and psychosis: An explorative study (abst – 2011) http://www.unboundmedicine.com/medli...orative_study_
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts – 2011) http://www.nature.com/neuro/journal/...n.2736_F1.html
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21087649
Endocannabinoid system dysfunction in mood and related disorders (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21916860
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids (abst – 2011) http://www.unboundmedicine.com/medli..._cannabinoids_
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst – 2011) http://www.unboundmedicine.com/medli...300_potential_
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21430651
Marijuana Use Associated With 'Superior' Cognitive Performance In Schizophrenic Patients, Study Says (news – 2011) http://www.norml.org/index.cfm?Group_ID=8537
A Brain Wrought Without Omega-3 (news – 2011) http://www.schizophreniaforum.org/ne...il.asp?id=1646
Debunking the Myth of a Link Between Marijuana and Mental Illness (news – 2011) http://www.alternet.org/drugs/151776
COMT; another “wrong†result for the reefer madness hype (news – 2011) http://ukcia.org/wordpress/?p=924
Synthetic cannabis linked to extended psychosis (news – 2011) http://medicalxpress.com/news/2011-0...psychosis.html
The Link Between Marijuana and Schizophrenia (news – 2011) http://www.time.com/time/health/arti...005559,00.html
Why Omega-3s Affect Your Mood (news – 2011) http://voices.yahoo.com/why-omega-3s...941.html?cat=5
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. (full – 2012) http://easap.asia/journal_file/1201_V22N1_p31.pdf
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full – 2012) http://www.biomedcentral.com/1471-244X/12/112
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full – 2012) http://link.springer.com/article/10..../fulltext.html
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full - 2012) http://onlinelibrary.wiley.com/doi/1...2.02175.x/full
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full – 2012) http://onlinelibrary.wiley.com/doi/1.../dta.1425/full
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cortical basket cell dysfunction in schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full– 2012) http://www.scielo.br/scielo.php?scri...rm=iso&tlng=en
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF – 2012) http://www.eurekaselect.com/102848/article
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst – 2012) http://www.sciencedirect.com/science...20996412001740
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22687521
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Neurocognitive functioning and cannabis use in schizophrenia (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Anandamide dysfunction in prodromal and established psychosis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst – 2012) http://www.springerlink.com/content/ur5784gm34782505/
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
'Cannabis' receptor discovery may help understanding of obesity and pain (news – 2012) http://phys.org/news/2012-08-cannabi...sity-pain.html
Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news – 2012) http://www.alternet.org/newsandviews...tic_disorders/
Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012) http://www.mhhub.com/archives/16603
Marijuana Compound May Beat Antipsychotics at Treating Schizophrenia (news – 2012) http://psychcentral.com/news/2012/06...nia/39803.html
Marijuana Use Linked to Better Adherence in Psychosis (news – 2012) http://www.clinicalpsychiatrynews.co...1010&tx_ttnews[tt_news]=138709
Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study (full – 2011) http://www.ajop.co.za/Journals/Novem...abis%20use.pdf
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full – 2011) http://www.hindawi.com/journals/sprt/2011/501726/
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NB...d-Micelles.pdf
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full – 2011) http://jop.sagepub.com/content/26/1/144.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis, COMT and psychotic experiences (full – 2011) http://bjp.rcpsych.org/content/199/5/380.long
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...h-05-00063.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives (full – 2011) http://jop.sagepub.com/content/26/1/150.full.pdf+html
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full – 2011) http://www.schres-journal.com/articl...224-6/fulltext
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21458498
Synthetic cannabinoid JWH-018 and psychosis: An explorative study (abst – 2011) http://www.unboundmedicine.com/medli...orative_study_
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts – 2011) http://www.nature.com/neuro/journal/...n.2736_F1.html
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21087649
Endocannabinoid system dysfunction in mood and related disorders (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21916860
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids (abst – 2011) http://www.unboundmedicine.com/medli..._cannabinoids_
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst – 2011) http://www.unboundmedicine.com/medli...300_potential_
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21430651
Marijuana Use Associated With 'Superior' Cognitive Performance In Schizophrenic Patients, Study Says (news – 2011) http://www.norml.org/index.cfm?Group_ID=8537
A Brain Wrought Without Omega-3 (news – 2011) http://www.schizophreniaforum.org/ne...il.asp?id=1646
Debunking the Myth of a Link Between Marijuana and Mental Illness (news – 2011) http://www.alternet.org/drugs/151776
COMT; another “wrong†result for the reefer madness hype (news – 2011) http://ukcia.org/wordpress/?p=924
Synthetic cannabis linked to extended psychosis (news – 2011) http://medicalxpress.com/news/2011-0...psychosis.html
The Link Between Marijuana and Schizophrenia (news – 2011) http://www.time.com/time/health/arti...005559,00.html
Why Omega-3s Affect Your Mood (news – 2011) http://voices.yahoo.com/why-omega-3s...941.html?cat=5
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. (full – 2012) http://easap.asia/journal_file/1201_V22N1_p31.pdf
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full – 2012) http://www.biomedcentral.com/1471-244X/12/112
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full – 2012) http://link.springer.com/article/10..../fulltext.html
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full - 2012) http://onlinelibrary.wiley.com/doi/1...2.02175.x/full
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full – 2012) http://onlinelibrary.wiley.com/doi/1.../dta.1425/full
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cortical basket cell dysfunction in schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full– 2012) http://www.scielo.br/scielo.php?scri...rm=iso&tlng=en
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF – 2012) http://www.eurekaselect.com/102848/article
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst – 2012) http://www.sciencedirect.com/science...20996412001740
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22687521
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Neurocognitive functioning and cannabis use in schizophrenia (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Anandamide dysfunction in prodromal and established psychosis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst – 2012) http://www.springerlink.com/content/ur5784gm34782505/
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
'Cannabis' receptor discovery may help understanding of obesity and pain (news – 2012) http://phys.org/news/2012-08-cannabi...sity-pain.html
Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news – 2012) http://www.alternet.org/newsandviews...tic_disorders/
Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012) http://www.mhhub.com/archives/16603
Marijuana Compound May Beat Antipsychotics at Treating Schizophrenia (news – 2012) http://psychcentral.com/news/2012/06...nia/39803.html
Marijuana Use Linked to Better Adherence in Psychosis (news – 2012) http://www.clinicalpsychiatrynews.co...1010&tx_ttnews[tt_news]=138709